Pharmaceutical Technology E-Alert:
Having trouble viewing this e-mail? Click here.
  Pharmaceutical Technology Europe E-Alert
 
13 July 2012
IN THIS ISSUE
New July Issue
GMP Deficiencies
Biologics' Drug Delivery
News Roundup
Top Technologies
 

Focusing on Injectables
This month, our July issue takes an in-depth look at the patient benefits and manufacturing challenges of extended-release injectables. Other top stories include biologics, GMP deficiencies and more. More...
 
EMA and MHRA Provide Insight into Increasing GMP Deficiencies
Drug deficiencies are increasing in Europe. Between 2009 and 2011, quality defects jumped from 80 to 154 and may be related to the growing number and scope of inspections. More...
 
Optimising Drug Delivery for Modern Biologics
Many of today’s biologic drugs pose issues relating to frequency of dosing, dose volume and delivery mechanisms, but there are potential opportunities for improving patient experiences with new technologies. More...
 
News bites
Our roundup of news presents the hot topics trending on Twitter and some of the biggest news that has hit the pharma industry’s headlines including Merck Serono’s restructuring, the EMA on biosimilars and more. More...
 
Top Technologies
The editors’ picks of some of the latest top technologies available for pharmaceutical manufacturers in Europe. More...

Key Topics:
Latest blog posts
Defining a Batch in Continuous Manufacturing
A New Era for Corporate Integrity
Healthcare Reform and Next Battles for Industry
More blog posts

Latest news
GSK Agrees to $3 Billion Settlement with Justice Department
Congress Passes Generic Drug Act
Bristol-Myers Squibb Agrees to Acquire Amylin for $5.3 Billion
More news

Upcoming events
New Pharmacovigilance Legislation - July 2012 - All Change for Europe (20–21 August | UK)
CPhI South America (21–23 August | Brazil)
Pharmaceutical Regulatory Summit (21–24 August | Singapore)
More events

Products/Service Profiles
Agilent

Realize Effective Pharmaceuticals
Reliable solutions enable pharmaceutical scientists to innovate in disease research, accelerate drug discovery and have greater confidence throughout development and manufacturing.
Read more

 
Nippon Soda Co., Ltd.

Nisso HPC (hydroxypropyl cellulose)
Special low viscosity, super fine powder grade Nisso HPC-SSL-SFP is introduced as a new high performance dry binder for direct compression, ODT and extra-granule addition applications. Read more

 
Shimadzu

LCMS-8080 triple quadrupole for LC/MS/MS analysis of complex matrices
Shimadzu has introduced the new LCMS-8080 triple quadrupole mass spectrometer which provides outstanding sensitivity with a large dynamic range and quantitation performance.
Read more


Event Profile

Pharma Integrates 2012
Nov 28-29 2012
London, UK
Where do you see partnerships strategically?
This is the central question that Pharma Integrates 2012 (PI2012) will tackle. PI2012 is the exclusive retreat for the bio/pharmaceutical procurement and outsourcing elite. Read more

Survey
Are you in favor of the US Supreme Court overturning the Affordable Care Act and its associated biosimilars pathway?
 
Yes 74%
 
 
No 21%
     
 
I am in favour of overturning the Act but keeping the biosimilars pathway in tact 5%

This week we would like to know...

Has your manufacturing site implemented an energy efficiency plan to reduce carbon footprint?

Click here to vote

Contact Us
Click here to contact editorial.

Click here to contact sales.